Regencell Bioscience Holdings Ltd
(RGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Operating Expenses | 3,770 | 4,737 | 6,274 | 7,618 | 1,381 |
| Operating Income | -3,770 | -4,737 | -6,274 | -7,618 | -1,381 |
| Other Income | 186 | 374 | 211 | 23 | 35 |
| Pre-tax Income | -3,584 | -4,363 | -6,062 | -7,595 | -1,347 |
| Net Income Continuous | -3,584 | -4,363 | -6,062 | -7,595 | -1,347 |
| Minority Interests | N/A | -61 | -191 | -149 | N/A |
| Net Income | $-3,584 | $-4,302 | $-5,871 | $-7,446 | $-1,347 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.01 | -0.01 | -0.02 | N/A |
| EBITDA(a) | $-3,692 | $-4,431 | $-5,981 | $-7,468 | $-1,355 |